Fitzsimon_menu

Find out what's happening on campus and across the industry.

Read Fitzsimons Innovation Community news, industry highlights, editorials, and innovation updates happening weekly on our campus.

Aurora Clears Path for 7,266 Homes to Anchor Fitzsimons Life Sciences Hub
News | Jun 26, 2025

Aurora Clears Path for 7,266 Homes to Anchor Fitzsimons Life Sciences Hub

Aurora City Council has approved a massive increase in allowable housing at Fitzsimons Innovation Community, a move intended to transform the bioscience campus into a full-fledged neighborhood. Fitzsimons CEO Kelly Brough called the change “an obligation” to honor the site’s history while shaping a future that attracts talent and builds community.

Fitzsimons Campus Poised to Include Thousands of New Housing Units
News | Jun 26, 2025

Fitzsimons Campus Poised to Include Thousands of New Housing Units

A change to the Fitzsimons Innovation Community’s master plan in Aurora will allow eight times more residential units to be built on the medical campus.The Aurora City Council on Monday approved an amendment to the general development plan that increases the Fitzsimons Innovation Community residential unit cap from 850 units to 7,266 new units. Changes also include improvements to street, utility, drainage, parks and open space on site. Kelly Jean Brough, President and CEO of Fitzsimons Innovation Community, said the change will bring together the grander vision of a more interconnected campus.

Gene-Edited Stem Cells Aim to Reverse Rheumatoid Arthritis
News | Jun 06, 2025

Gene-Edited Stem Cells Aim to Reverse Rheumatoid Arthritis

A new approach for gene editing will get its shot in a common and chronic autoimmune disorder. Rheumatoid arthritis is an autoimmune disease that causes pain and swelling in the joints. It affects about one percent of the adult population. With its HLA gene editing approach, RheumaGen believes it can create a one-time cure for rheumatoid arthritis that solves for uncontrolled disease and ineffective therapies.

RheumaGen Betting on HLA Gene Editing to Tackle Autoimmune Disorders
News | May 30, 2025

RheumaGen Betting on HLA Gene Editing to Tackle Autoimmune Disorders

A startup is developing a new class of treatments for autoimmune diseases leveraging an approach to editing genes in the HLA family, which play a critical role in the immune system. RheumaGen, which spun out from the University of Colorado Anschutz Medical Campus, launched earlier this year with $15 million in Series A funding co-led by investment firms SPRIM Global Investments and William Taylor Nominees. The company focuses on autoimmune conditions with genetic risk factors linked with certain variants in HLA genes.

Aurora Lands on List of 100 Best Places to Live in US
News | May 16, 2025

Aurora Lands on List of 100 Best Places to Live in US

A new study from Livability finds a lot to love along the Front Range, naming Aurora, Loveland, and Colorado Springs to a list of the 100 best places to live in the U.S. “Living in Aurora means residents can take full advantage of the city’s excellent amenities and strong economy,” the site said. “Biotech startups, hospitals and defense contractors provide locals with well-paying jobs. Another advantage of living in Aurora is its central location. Residents are close to Denver International Airport and can hop on I-70 to get to the mountains.”

CREJ: Fitzsimmons and CBRE: A Market Outlook for 2025 and Beyond
News | Apr 21, 2025

CREJ: Fitzsimmons and CBRE: A Market Outlook for 2025 and Beyond

Each quarter the Colorado Real Estate Journal publishes its Healthcare and Life Sciences Quarterly to report on the state of commercial real estate in Colorado. The most recent edition includes an article from Fitzsimons and our leasing partners at CBRE to explore the forecast for life sciences real estate markets in our region, and why Fitzsimons is uniquely positioned to welcome new life sciences companies to our supportive campus.

Aurora Now Interviews Kelly Brough About Fitzsimons' Momentum
News | Apr 16, 2025

Aurora Now Interviews Kelly Brough About Fitzsimons' Momentum

Aurora's Fitzsimons Innovation Community is saving lives, literally! It's home to all kinds of cutting-edge life science companies that are coming up with ways to improve medical technology and patient care. AuroraTV talks with Fitzsimons' new President and CEO, Kelly Brough, about what lies ahead.

Fitzsimons Innovation Community Strives to Expand Hub for Science and Healthcare
News | Apr 14, 2025

Fitzsimons Innovation Community Strives to Expand Hub for Science and Healthcare

What Aurora officials say is an industrious Fitzsimons Innovation Community could also become a community where scientists don’t just work, but also live and play while exploring bio and life science. “Aurora saw the vision that said this could be home to healthcare, bio and life science center for the state of Colorado, and today, we boast one of the largest bioscience communities in the nation,” Kelly Brough, the executive director for the Fitzsimons Innovation Committee told Aurora lawmakers at a recent update during the study session April 7.

Melissa Krebs Inducted Into American Institute for Medical and Biological Engineering College of Fellows
News | Apr 14, 2025

Melissa Krebs Inducted Into American Institute for Medical and Biological Engineering College of Fellows

Melissa Krebs, Ph.D., CEO and Founder of Community member GelSana, has been inducted into the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows. ​This prestigious honor recognizes her pioneering advancements in cell-interactive biomaterials and their clinical translation, particularly in regenerative medicine and drug delivery technologies. Her innovative work is making significant strides in improving patient outcomes and quality of life.

RefinedScience Completes Office and Lab Buildout
News | Apr 07, 2025

RefinedScience Completes Office and Lab Buildout

BNBuilders announced the completion of a new 5,500-square-foot office and lab space for RefinedScience at the Fitzsimons Innovation Community Campus. This modern, functional environment is designed to support scientific innovation and enhance collaboration.

Groundbreaking Results from CPC Clinical Research-led STRIDE Trial
News | Apr 03, 2025

Groundbreaking Results from CPC Clinical Research-led STRIDE Trial

This Phase 3b trial suggests that semaglutide 1.0 mg (Ozempic) could become the first therapy in nearly 20 years to gain regulatory approval for improving functional outcomes in patients with peripheral artery disease (PAD) and type 2 diabetes (T2D). sciences real estate markets in our region, and why Fitzsimons is uniquely positioned to welcome new life sciences companies to our supportive campus.

Aurora coffee shop offers job training for people experiencing homelessness
News | Apr 02, 2025

Aurora coffee shop offers job training for people experiencing homelessness

Change Please Coffee at Fitzsimons Innovation Community in Aurora is a coffee shop that is doing good in the community by helping people get back on their feet.